Table. Demographic and clinical data and sample characteristics for notified Klebsiella pneumoniae with a confirmed NDM-1 carbapenemase, Germany, weeks 10–43/2022 (n = 75).
Patient information | Total | With reported country location of exposure | |||
---|---|---|---|---|---|
n | % | Germany or foreign country other than Ukraine | Ukraine | ||
All | Co-production of NDM-1 and OXA-48(-like) carbapenemases | ||||
Sex | 75 | 100 | 19 | 24 | 12 |
Female | 32 | 43 | 11 | 8 | 4 |
Male | 42 | 56 | 8 | 15 | 7 |
Missing | 1 | 1 | 0 | 1 | 1 |
Median age in years (IQR) | 49 (34–66) | 63 (46–72) | 41 (34–47) | 40 (29–45) | |
Missing | 0 | 0 | 0 | 0 | |
Sampling material a | |||||
Blood/liquor | 7 | 9 | 2 | 1 | 1 |
Urine | 14 | 19 | 9 | 1 | 0 |
Wound | 17 | 23 | 1 | 9 | 4 |
Screening/stool | 31 | 41 | 6 | 11 | 5 |
Other or missing | 6 | 8 | 1 | 2 | 2 |
Infections vs colonisationsb | |||||
Infections | 39 | 52 | 13 | 11 | 5 |
Colonisations | 34 | 45 | 6 | 13 | 7 |
Missing | 2 | 3 | 0 | 0 | 0 |
IQR: interquartile range.
a Sampling material was documented as multiple choice but evaluated here by selecting the first material mentioned in the order: blood/liquor, urine, wound, screening/stool.
b Infection vs colonisation was inferred from the sampling material (from blood/liquor/urine/wound vs screening/stool, respectively), and from the classification as in the notification if the information on material was missing.